130 related articles for article (PubMed ID: 37086131)
21. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.
Terai K; Dong GZ; Oh ET; Park MT; Gu Y; Song CW; Park HJ
Anticancer Drugs; 2009 Nov; 20(10):901-9. PubMed ID: 19738461
[TBL] [Abstract][Full Text] [Related]
23. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
24. A CaO
Chen F; Yang B; Xu L; Yang J; Li J
ChemMedChem; 2021 Jul; 16(14):2278-2286. PubMed ID: 33792182
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors.
Liu Y; Zhang J; Du J; Song K; Liu J; Wang X; Li B; Ouyang R; Miao Y; Sun Y; Li Y
Acta Biomater; 2021 Jul; 129():280-292. PubMed ID: 34033970
[TBL] [Abstract][Full Text] [Related]
26. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
[TBL] [Abstract][Full Text] [Related]
27. Nanocatalyst-Mediated Chemodynamic Tumor Therapy.
Zhang L; Li CX; Wan SS; Zhang XZ
Adv Healthc Mater; 2022 Jan; 11(2):e2101971. PubMed ID: 34751505
[TBL] [Abstract][Full Text] [Related]
28. Ultrasensitive Chemodynamic Therapy: Bimetallic Peroxide Triggers High pH-Activated, Synergistic Effect/H
Zhou H; Li X; Niu D; Li Y; Liu X; Li C; Si W; Cao J; Song Y; Wen G; Niu Z; Zhang L
Adv Healthc Mater; 2021 May; 10(9):e2002126. PubMed ID: 33644985
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
[TBL] [Abstract][Full Text] [Related]
30. Carnosic acid, an inducer of NAD(P)H quinone oxidoreductase 1, enhances the cytotoxicity of β-lapachone in melanoma cell lines.
Arakawa N; Okubo A; Yasuhira S; Takahashi K; Amano H; Akasaka T; Masuda T; Shibazaki M; Maesawa C
Oncol Lett; 2018 Feb; 15(2):2393-2400. PubMed ID: 29434949
[TBL] [Abstract][Full Text] [Related]
31. Anti-cancer effect of bio-reductive drug beta-lapachon is enhanced by activating NQO1 with heat shock.
Song CW; Chae JJ; Choi EK; Hwang TS; Kim C; Lim BU; Park HJ
Int J Hyperthermia; 2008 Mar; 24(2):161-9. PubMed ID: 18283592
[TBL] [Abstract][Full Text] [Related]
32. One-Pot Rapid Synthesis of Cu
Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
[TBL] [Abstract][Full Text] [Related]
33. Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.
Bey EA; Reinicke KE; Srougi MC; Varnes M; Anderson VE; Pink JJ; Li LS; Patel M; Cao L; Moore Z; Rommel A; Boatman M; Lewis C; Euhus DM; Bornmann WG; Buchsbaum DJ; Spitz DR; Gao J; Boothman DA
Mol Cancer Ther; 2013 Oct; 12(10):2110-20. PubMed ID: 23883585
[TBL] [Abstract][Full Text] [Related]
34. β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol.
Steinmeier J; Kube S; Karger G; Ehrke E; Dringen R
Neurochem Res; 2020 Oct; 45(10):2442-2455. PubMed ID: 32789798
[TBL] [Abstract][Full Text] [Related]
35. A Harmless-Harmful Switchable and Uninterrupted Laccase-Instructed Killer for Activatable Chemodynamic Therapy.
Zhou TJ; Xu Y; Xing L; Wang Y; Jiang HL
Adv Mater; 2021 Jul; 33(27):e2100114. PubMed ID: 34062021
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
[TBL] [Abstract][Full Text] [Related]
37. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
[TBL] [Abstract][Full Text] [Related]
38. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of radiation effect using beta-lapachone and underlying mechanism.
Ahn KJ; Lee HS; Bai SK; Song CW
Radiat Oncol J; 2013 Jun; 31(2):57-65. PubMed ID: 23865001
[TBL] [Abstract][Full Text] [Related]
40. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
